Abstract:Malaria parasite Plasmodium falciparum uses multiple receptors on the surface of human red blood cells to attach and invade host cells during blood stage infection. Glycophorins, including glycophorin A, B, and C have been implicated as host receptors and play an important role during Plasmodium falciparum invasion in human erythrocytes, particularly in the sialic acid-dependent parasite strains. To identify the parasite proteins that could bind to human glycophorins, we screened a phage display cDNA library of P. falciparum (FCR3 strain, a sialic acid-dependent strain) using human glycophorins and native intact human erythrocytes as bait. After four rounds of library screening and panning, 35 phage clones were identified that bound to purified glycophorins immobilized on the plastic surface. DNA sequencing of 12 phage clones revealed that they encode the same 7-amino acid sequence, ETTLKSF. Using immobilized intact human erythrocytes, a similar screening strategy led to the isolation of additional 20 phage clones, and the DNA sequencing of 6 such clones again revealed the same 7-amino acid sequence, ETTLKSF. In vitro binding of synthetic ETTLKSF peptide to purified glycophorins and intact erythrocytes was confirmed by ELISA and indirect immunofluorescence assays. Pull-down experiments demonstrated that the ETTLKSF peptide specifically interacts with glycophorin C, but not with glycophorin A and B, on human erythrocytes. The synthetic ETTLKSF peptide blocked merozoite invasion of P. falciparum in human erythrocytes in a dose-dependent manner, whereas the control peptides were without any effect. We have named the ETTLKSF peptide as GBL-1, the Glycophorin Binding Ligand-1. We propose that further characterization of GBL-1, the first peptide ligand that specifically binds to human glycophorin C, could lead to the development of novel anti-malarial agents that prevent P. falciparum invasion in human erythrocytes via the glycophorin C receptor.

Identification of GAPDH on the surface of Plasmodium sporozoites as a new candidate for targeting malaria liver invasion

Identification of Plasmodium GAPDH epitopes for generation of antibodies that inhibit malaria infection

Functional Human IgA Targets a Conserved Site on Malaria Sporozoites

Plasmodium sporozoite phospholipid scramblase interacts with mammalian carbamoyl-phosphate synthetase 1 to infect hepatocytes

Receptor-Based Identification of Novel Peptide Ligands As Inhibitors of Blood Stage Malaria.

128A Whole-Blood Transcriptional Signature Predicts Parasite Control and Protection from Malaria Fever During Natural Plasmodium Falciparum Infection

CD68 acts as a major gateway for malaria sporozoite liver infection

Identification of Targets of CD8+ T Cell Responses to Malaria Liver Stages by Genome-wide Epitope Profiling

Receptor-based identification of an inhibitory peptide against blood stage malaria.

A screen for Plasmodium falciparum sporozoite surface protein binding to human hepatocyte surface receptors identifies novel host–pathogen interactions

Plasmodium P36 determines host cell receptor usage during sporozoite invasion

A Plasmodium late liver stage arresting GAP provides superior protection in mice

Merozoite Surface Protein 1 Recognition of Host Glycophorin A Mediates Malaria Parasite Invasion of Red Blood Cells.

Overlapping and distinct roles of CDPK family members in the pre-erythrocytic stages of the rodent malaria parasite, Plasmodium berghei

Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stages

Targeting Plasmodium Life Cycle with Novel Parasite Ligands as Vaccine Antigens

Identification of a specific region of Plasmodium falciparum EBL-1 that binds to host receptor glycophorin B and inhibits merozoite invasion in human red blood cells.

An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs

A Co-ligand Complex Anchors Plasmodium Falciparum Merozoites to the Erythrocyte Invasion Receptor Band 3

Genetic and chemical validation of Plasmodium falciparum aminopeptidase Pf A-M17 as a drug target in the hemoglobin digestion pathway

Role of host cell traversal by the malaria sporozoite during liver infection